From research to real-world care, delivering WHO-prequalified vaccines and therapies that save lives
Comprehensive solutions for developing, manufacturing, and bringing life-saving vaccines and biotherapeutic products to global markets.
Global healthcare leadership in vaccines and biotherapeutics
Provaxa is at the forefront of global healthcare innovation, pioneering vaccines and biotherapeutics that are transforming lives worldwide. Our relentless pursuit of scientific breakthroughs is driven by a deep commitment to solving urgent medical challenges and shaping the future of medicine.
With cutting-edge research and breakthrough technologies, we have developed vaccines and biotherapeutic products that are redefining public health standards and offering hope to millions across the globe. Integrity guides every step, from data accuracy to patient safety, ensuring our work inspires trust and lasting impact.
Present in over 50 countries with a team of 200+ professionals including research scientists and manufacturing experts, we combine visionary science with compassionate care to build healthier, stronger communities around the world. Our immuno-biologics focus is dedicated to developing and manufacturing life-saving vaccines and therapeutic products that meet WHO prequalification standards.
We are committed to making life-saving treatments accessible and affordable for all, delivering integrated solutions that address urgent global health needs while maintaining the highest standards of quality, safety, and efficacy.
Provaxa's global presence spans 50+ countries with strategic partnerships across Europe, Africa, Southeast Asia, and the USA. Our integrated network and regional expertise enable us to develop vaccines and biotherapeutics that address diverse public health challenges while maintaining consistent quality and regulatory compliance across all markets.
Integrated services from discovery to commercial scale production
Expert guidance through the complex biopharmaceutical product development landscape. We specialize in integrated product development, helping clients navigate challenges from discovery through clinical stages and commercialization.
Cutting-edge research utilizing advanced technologies and methodologies to identify and develop promising drug candidates targeting diverse diseases. We specialize in creating and optimizing biologic drugs including monoclonal antibodies, recombinant proteins, and gene therapies.
Innovative design of drug formulations and delivery systems that improve stability, bioavailability, and patient adherence. Our scientists develop next-generation formulations optimized for clinical efficacy and commercial scalability.
Comprehensive contract development and manufacturing services for clinical and commercial supply. Our state-of-the-art facilities and experienced team ensure high-quality biopharmaceutical production meeting the highest standards.
Ensuring product safety, purity, and efficacy through precise testing and rigorous quality control. Our cutting-edge laboratories staffed by seasoned scientists deliver accurate, reliable analytical results supporting regulatory submissions.
Specialized in facilitating smooth and efficient technology transfers within the biopharmaceutical sector. We manage comprehensive knowledge sharing, process documentation, and manufacturing validation to ensure successful commercialization.
Our comprehensive approach integrates advanced scientific research, innovative manufacturing, rigorous quality control, and regulatory expertise to bring transformative biopharmaceutical products to patients worldwide. From bench to bedside, we ensure excellence at every stage.
Meeting the highest international standards for vaccine and biotherapeutic manufacturing
Provaxa maintains unwavering commitment to WHO prequalification standards and GMP compliance across all manufacturing operations. Our facilities, processes, and quality systems are designed to meet or exceed the stringent requirements of the World Health Organization, enabling products to reach patients in developing and developed markets alike.
We understand that WHO prequalification represents the gold standard for vaccine and biotherapeutic products destined for global markets, particularly in resource-limited settings. Our manufacturing expertise and regulatory knowledge ensure seamless navigation of WHO prequalification pathways while maintaining cost-effectiveness and rapid market entry.
Our commitment to WHO prequalification encompasses:
Our GMP-compliant operations ensure highest quality standards:
Our manufacturing facilities maintain ISO certifications and WHO GMP compliance with rigorous internal audit programs ensuring continuous adherence to global quality standards. We invest continuously in facility upgrades, equipment maintenance, and staff training to support successful regulatory inspections and product approvals.
Comprehensive clinical study design and execution supporting regulatory approval
We are committed to advancing biopharmaceuticals through thorough research and well-conducted clinical studies. Our mission focuses on developing innovative therapies that enhance patient outcomes and improve quality of life. Our skilled team of researchers, scientists, and medical professionals is dedicated to delivering high-quality clinical study execution across all phases.
We provide a full suite of services supporting every phase of the clinical study journey, from study design and protocol development to data analysis and regulatory submissions. Our expertise in immuno-biologics ensures specialized protocols, precise safety monitoring, and optimized data collection for vaccines and biotherapeutic products.
Safeguarding innovations, products, and brands in the biopharmaceutical landscape
Developing biopharmaceutical products requires navigating a complex landscape of scientific research, clinical studies, regulatory compliance, and intellectual property (IP) management. We provide guidance and support on protecting innovations, products, and brands through patents, trademarks, copyrights, and trade secrets.
✓ Comprehensive IP strategy development
✓ Protection of innovations and competitive advantage
✓ Support for market exclusivity and commercialization
In-licensing, out-licensing, and import-export solutions for biopharmaceutical innovation
Strategic partnerships bringing together companies with complementary strengths to enhance product pipelines, achieve scale, advance technologies, and successfully launch commercial products globally.
New technologies with potential to evolve into vaccines or therapeutics are licensed through clear, transparent strategies ensuring affordable access in underserved regions while enabling cost recovery and accelerated market entry.
Expert guidance navigating the complex import-export sector offering significant opportunities in global trade. We support clients in obtaining necessary licenses, ensuring regulatory compliance, and executing successful international transactions.
Strategic branding expertise setting your biopharmaceutical products apart from competitors and building lasting customer loyalty. Our approach turns ordinary brands into memorable leaders influencing every aspect of your business.
Strategic licensing and partnership approaches enabling companies to recover research and development costs, leverage licensee expertise, access cutting-edge technologies, lower development costs and risks, and successfully launch products to global markets.
Comprehensive partnership and licensing strategies that mitigate development risks, accelerate time-to-market, broaden product portfolios, and ensure sustainable commercialization across diverse global markets and regulatory environments.
Proven expertise delivering transformative vaccines and biotherapeutics to global markets
Presence in 50+ countries with 200+ professionals delivering integrated solutions and regional expertise enabling successful product development and commercialization across diverse markets.
Deep experience navigating WHO prequalification pathways with proven track record of successful product approvals enabling access to emerging markets and government procurement programs worldwide.
State-of-the-art GMP-compliant facilities equipped with cutting-edge technology supporting clinical and commercial scale production of vaccines and biotherapeutic products meeting highest quality standards.
End-to-end capabilities spanning discovery, development, manufacturing, quality control, and regulatory support ensuring seamless advancement from laboratory innovation to patient access globally.
Experienced team of scientists, researchers, and manufacturing experts dedicated to discovering and developing breakthrough therapies addressing unmet medical needs with innovation and rigor.
Commitment to making life-saving treatments accessible and affordable, driven by vision of building healthier communities worldwide through compassionate science and responsible innovation.
How we support your Biopharmaceuticals product development journey
Evaluate your product concept, regulatory pathway, and development needs
Design integrated product development plan aligned with regulatory requirements
Expert execution with quality oversight and regulatory alignment throughout
Support for regulatory approvals, commercialization, and global market access
Throughout every step, our integrated team remains your dedicated partner, ensuring scientific excellence, regulatory compliance, and successful global commercialization of life-saving vaccines and biotherapeutics.
Partner with Provaxa to develop, manufacture, and bring WHO-prequalified vaccines and biotherapeutic products to patients worldwide.
Provaxa is proudly powered by WordPress